These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7587115)

  • 1. Barrett's esophagus: a model of human neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Cowan DS; Ramel S; Levine DS; Reid BJ
    Cold Spring Harb Symp Quant Biol; 1994; 59():577-83. PubMed ID: 7587115
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.
    Reid BJ; Prevo LJ; Galipeau PC; Sanchez CA; Longton G; Levine DS; Blount PL; Rabinovitch PS
    Am J Gastroenterol; 2001 Oct; 96(10):2839-48. PubMed ID: 11693316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.
    Chao DL; Maley CC; Wu X; Farrow DC; Galipeau PC; Sanchez CA; Paulson TG; Rabinovitch PS; Reid BJ; Spitz MR; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1935-40. PubMed ID: 17035402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoplastic risk assessment in Barrett's esophagus: How far have we come?
    Noffsinger A
    Hum Pathol; 2003 Oct; 34(10):965-7. PubMed ID: 14608528
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Walch A; Mueller J; Höfler H; Werner M
    J Natl Cancer Inst; 2000 Jul; 92(14):1182-3. PubMed ID: 10904093
    [No Abstract]   [Full Text] [Related]  

  • 6. Barrett's esophagus: the biology of neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Levine DS; Reid BJ
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D71-6. PubMed ID: 8013790
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
    Smith CM; Watson DI; Michael MZ; Hussey DJ
    World J Gastroenterol; 2010 Feb; 16(5):531-7. PubMed ID: 20128019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression to cancer in Barrett's esophagus is associated with genomic instability.
    Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE
    Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ
    J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus: model of neoplastic progression.
    Ramel S
    World J Surg; 2003 Sep; 27(9):1009-13. PubMed ID: 12917763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Obesity Associated with Barrett's Esophagus and Esophageal Adenocarcinoma?
    Lynch KL
    Gastroenterol Clin North Am; 2016 Dec; 45(4):615-624. PubMed ID: 27837776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-segment Barrett's esophagus associated with high-grade dysplasia.
    Morita K; Fujimori T; Ono Y; Masuyama H; Nakamura T; Terano A
    J Gastroenterol; 2002; 37(12):1083-5. PubMed ID: 12522544
    [No Abstract]   [Full Text] [Related]  

  • 15. Barrett's: do we still need goblet cells for diagnosis?
    Lenglinger J; Riegler M
    Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphometric observations on some aspects of Barrett's esophagus.
    Fichera G; Macaluso G
    Pathologica; 1988; 80(1067):333-41. PubMed ID: 3070468
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus.
    Doak SH; Jenkins GJ; Parry EM; D'Souza FR; Griffiths AP; Toffazal N; Shah V; Baxter JN; Parry JM
    Gut; 2003 May; 52(5):623-8. PubMed ID: 12692043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for neoplastic progression in Barrett's esophagus.
    Wiseman EF; Ang YS
    World J Gastroenterol; 2011 Aug; 17(32):3672-83. PubMed ID: 21990948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrett's esophagus and esophageal adenocarcinoma.
    Reid BJ
    Gastroenterol Clin North Am; 1991 Dec; 20(4):817-34. PubMed ID: 1787015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus: ordering the events that lead to cancer.
    Reid BJ; Barrett MT; Galipeau PC; Sanchez CA; Neshat K; Cowan DS; Levine DS
    Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():57-65. PubMed ID: 9061296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.